How to construct transgenic mice



Similar documents
How to construct transgenic mice

How to construct transgenic mice

Design of conditional gene targeting vectors - a recombineering approach

Answer Key Problem Set 5

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

Von Mäusen und Menschen E - 1

2.1.2 Characterization of antiviral effect of cytokine expression on HBV replication in transduced mouse hepatocytes line

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.

The automated mouse: Systematic generation of disease models

Becker Muscular Dystrophy

restriction enzymes 350 Home R. Ward: Spring 2001

Chapter 8: Recombinant DNA 2002 by W. H. Freeman and Company Chapter 8: Recombinant DNA 2002 by W. H. Freeman and Company

CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA

GeneCopoeia Genome Editing Tools for Safe Harbor Integration in. Mice and Humans. Ed Davis, Liuqing Qian, Ruiqing li, Junsheng Zhou, and Jinkuo Zhang

LONDON REGIONAL TRANSGENIC AND GENE TARGETING FACILITY

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College

Chapter 5: Organization and Expression of Immunoglobulin Genes

CCR Biology - Chapter 9 Practice Test - Summer 2012

OKT3. ~ The first mouse monoclonal antibody. used in clinical practice in the field of transplantation ~

Integrated Protein Services

Guidance. 2. Definitions. 1. Introduction

Recombinant DNA Technology

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

Appendix 2 Molecular Biology Core Curriculum. Websites and Other Resources

Animal Pharming: The Industrialization of Transgenic Animals December 1999

Recombinant DNA and Biotechnology

CHARACTERISTIC FEATURES OF STEM CELLS. CLONING TECHNOLOGIES

Chapter 16 Reproductive Technology, Gene Therapy, and Stem Cells (modified)

DNA Fingerprinting. Unless they are identical twins, individuals have unique DNA

Human hybridoma technology for the production of monoclonal antibodies

Autoimmunity and immunemediated. FOCiS. Lecture outline

EUCOMMçthe European Conditional Mouse Mutagenesis Program Roland H. Friedel, Claudia Seisenberger, Cornelia Kaloff and Wolfgang Wurst

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.

Understanding the immune response to bacterial infections

Geniron. Custom Antibody Services. Serum services Antibody Monoclonal. Purification Antibody Mono Y Genetic Immunization Genbody Polyclonal Antibody

Aviva Systems Biology

Disclosure. Gene Therapy. Transfer of genes into cells Expression of transferred genes

Genetic Engineering and Biotechnology

Novel method to load a mammalian artificial chromosome. (MAC) with multiple genes

Genetic Technology. Name: Class: Date: Multiple Choice Identify the choice that best completes the statement or answers the question.

Bacterial Transformation Post lab Questions:

Why use passive immunity?

The Journal of Experimental Medicine

Problem Set 6 KEY

Basics of Immunology

Protein Expression. A Practical Approach J. HIGGIN S

(1-p) 2. p(1-p) From the table, frequency of DpyUnc = ¼ (p^2) = #DpyUnc = p^2 = ¼(1-p)^2 + ½(1-p)p + ¼(p^2) #Dpy + #DpyUnc

B Cells and Antibodies

MRC-Holland MLPA. Description version 12;

Supplemental Information. McBrayer et al. Supplemental Data

KMS-Specialist & Customized Biosimilar Service

3 Chapter Three: Material and methods (clone creation, upstream and downstream process)

Give a NOD to diabetes:

Human Cloning The Science and Ethics of Nuclear Transplantation

Biotechnology: DNA Technology & Genomics

Expression and Purification of Recombinant Protein in bacteria and Yeast. Presented By: Puspa pandey, Mohit sachdeva & Ming yu

Leukemia Research Foundation Scientific Research Grant Recipients

Genetics 301 Sample Final Examination Spring 2003

LECTURE 6 Gene Mutation (Chapter )

Advanced BioDesign Outlines Solutions. Antibody Overview. by Advanced BioDesign. Project Start. Immunogenicity. Selecting Your Antigen

Microbiology AN INTRODUCTION EIGHTH EDITION

MAB Solut. MABSolys Génopole Campus 1 5 rue Henri Desbruères Evry Cedex. is involved at each stage of your project

On the origin of giant multinuclear Reed-Sternberg cells and the role of CD4 T cells in Hodgkin lymphoma

A Genetic Analysis of Rheumatoid Arthritis

BioMmune Technologies Inc. Corporate Presentation 2015

How To Expand Hematopoietic Stem Cells

Trasposable elements: P elements

Integrated Protein Services

B Lymphocyte (B cell)

An Improved Flp Deleter Mouse in C57Bl/6 Based on Flpo Recombinase

GENE CLONING AND RECOMBINANT DNA TECHNOLOGY

Introductory genetics for veterinary students

RNA Viruses. A Practical Approac h. Alan J. Cann

Gene Therapy and Genetic Counseling. Chapter 20

TG1050, A NOVEL IMMUNOTHERAPEUTIC TO TREAT CHRONIC HEPATITIS B, CAN CONTROL HBsAg AND PROVOKE HBsAg SEROCONVERSION IN HBV-PERSISTENT MOUSE MODELS

RNAi. Martin Latterich

Chapter 8. Summary and Perspectives

Forensic DNA Testing Terminology

Gene mutation and molecular medicine Chapter 15

BVIG/SBMI Meeting Bart N. Lambrecht, MD, PhD. Department of Respiratory Diseases University Hospital Gent, Belgium

Antigenic variation in Plasmodium falciparum : Erythrocyte invasion and immune escape mechanisms

Antibody Function & Structure

Transgenic technology in the production of therapeutic proteins

HuCAL Custom Monoclonal Antibodies

Recombinant DNA Unit Exam

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

Stem Cell Quick Guide: Stem Cell Basics

Chapter 18: Applications of Immunology

Compiled and/or written by Amy B. Vento and David R. Gillum

HuCAL Custom Monoclonal Antibodies

Transcription:

How to construct transgenic mice Sandra Beer-Hammer Autumn School 2010 Bad Schandau

Methods additional genetic information transgenic mouse line gene inactivation gene-deficient knockout mouse line Jak2 -/- Seite 2

Transgenic Mice Seite 3

Generation of Transgenic Mice holding pipette cloned gene 1-cell embryos at pronuclear stage injection pipette Seite 4

Microinjection of DNA Holding pipette Injection pipette Embryo (1-cell stadium) Seite 5

Construction of DNA and Expression Control T- and B-cell specific promotor (B. Iritani, 1997) Seite 6

Protein Expression in T and B Cells Seite 7

Gene Deficient Mice knock-out Jak2 -/- Seite 8

Gene Targeting Method - Overview from Capecchi, 1998 Seite 9

Targeting Construct - Design A 17 kb E probe A A X E LTβR: Genomic locus Targeting vector exon 1 2 3 4 5 6 7 8 9 10 4 kb E neo HSV-TK E probe A neo E E Targeted allele 1 kb Neo: HSV-TK: positive selection negative selection Seite 10

Transfection of ES Cells Seite 11

Targeting Verification E14 wt +/- kb 17.0 4.0 Southern Blot Seite 12

Isolation of Blastocysts (C57/BL6) Seite 13

Injection of ES Cells Holding pipette Blastocyst (2.5 days) Injection pipette with ES cells Seite 14

Chimeric Offspring Seite 15

Testing of Germline Transmission Aguti mice carry one allele of the mutated gene E14 mice wt +/- +/- wt kb 17.0 4.0 Chimeric mice are mated with C57/BL6 mice Southern Blot Seite 16

Verification of KO +/+ +/- -/- kb 2.0 LTβR 1.2 GAPDH Northern Blot Western Blot Seite 17

Phenotype Analyses - Organ size and morphology - Immune cell subpopulations (frequency, function) - Immune response in vitro (Proliferation, Cytokine production) - Immune response in vivo (Immunisation with Ficoll, CGG) - Defense of infections (Listeria, Toxoplasma, etc.) - Immune tolerance (Transplantation of Skin, Heart, Kidney) - Autoimmunity and Allergy (DTH, Asthma, etc.) - etc. Seite 18

Organ Size and Morphology Impaired Organogenesis of LNs without LTβR Seite 19

Immune Cell Subpopulations Reduced DP and SP Thymocytes in SLy1-deficient Mice Seite 20

Immune Response in vivo OD 405nm 0.6 0.5 0.4 0.3 0.2 0.1 TNP-Ficoll: IgM *** * *** * OD 405nm 0,15 0,12 0,09 0,06 0,03 TNP-Ficoll: IgG2a * ** OD 405nm 0,15 0,12 0,09 0,06 0,03 TNP-Ficoll: IgG3 * d0 d4 d7 d14 d21 d0 d4 d7 d14 d21 d0 d4 d7 d14 d21 OD 405nm 0.4 0.3 0.2 0.1 TNP-CGG: IgM KO WT OD 405nm 0.7 0.6 0.5 0.4 0.3 0.2 0.1 TNP-CGG: IgG1 ** * OD 405nm 0.6 0.5 0.4 0.3 0.2 0.1 TNP-CGG: IgG2a * * d0 d4 d7 d14 d21 d0 d4 d7 d14 d21 d0 d4 d7 d14 d21 Impaired Antibody Production in SLy1-deficient Mice Seite 21

Immune Tolerance H-2 bxd H-2 b Transplant survival (%) 100 80 60 40 20 H-2 b H-2 b, wt (n=5) H-2 bxd H-2 b, wt (n=8) H-2 bxd H-2 b, sly-/- (n=10) 10 20 30 40 50 60 days Increased Allograft Survival in SLy1-deficient Mice Seite 22

Conditional Gene-Targeting neo genetically modified ES cell Seite 23

Procaryotic Rekombinase Systems neo transient Cre (Frt, Flrt) Expression complete / multiple deletions (long distance deletions) conditional gene targeting Seite 24

Cre-mediated Deletion in vivo X Cre Gene-targeted mouse Cre mouse (deleter or tissue/cell-specific) Cre constitutive or inducible deletion of gene of interest Seite 25

The Cre-Zoo (constitutive or inducible) Lck DN T cells CD4 DP T cells FoxP3 Treg cell CD19 B cells Mb1 early B cells CD45 Lymphocytes F4/80 Macrophages, Kupffer cells CD11c DCs Albumin Hepatocytes Tie1/2 Endothelial cells etc. Seite 26

BAC Transgenic (or knock-out) Mice Seite 27

BAC Transgenic (or knock-out) Mice Fluorescent proteins Light-inducible cation channel Cre expression Cre inducible DTR Inducible Cre Inducible gene expression LacZ expression Light-inducible anion channel From Johansson, Genesis 2010 Seite 28

Find the Right BAC (bacterial artificial chromosome www.ensembl.org From Johansson, Genesis 2010 Seite 29

BAC Transgenic Mice Purify DNA and inject into pronucleus From Johansson, Genesis 2010 Seite 30

ET cloning versus Recombineering From Johansson, Genesis 2010 Seite 31

ET cloning versus Recombineering From Johansson, Genesis 2010 Seite 32

BAC knock-out Seite 33

BAC knock-out Method Overview I 1.) Creating the targeting vector with homologues recombination in E. coli pbad electroporate WI1 2.) 28 C NEO r electroporate pbad WI1 3.) Picking Kana/Chloramph resistant clones / check by PCR + DNA restriction Seite 34

BAC Knock-out Method Overview II 4.) pbad electroporate WI1 +NEO 28 C 5.) Thymidine kinase electroporate pbad WI1 +NEO 6.) Picking Amp/Kana/Chloramph resistant clones / check by PCR + DNA restriction Seite 35

Verification of Modified BAC Purify DNA and electroporate into ES cells Seite 36